Circulating tumor cells shielded with extracellular vesicle-derived CD45 evade T cell attack to enable metastasis
Authors:
Open Access
- 5 April 2024
- journal article
- research article
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 9 (1) , 1-18
Abstract
Circulating tumor cells (CTCs) are precursors of distant metastasis in a subset of cancer patients. A better understanding of CTCs heterogeneity and how these CTCs survive during hematogenous dissemination could lay the foundation for therapeutic prevention of cancer metastasis. It remains elusive how CTCs evade immune surveillance and elimination by immune cells. In this study, we unequivocally identified a subpopulation of CTCs shielded with extracellular vesicle (EVs)-derived CD45 (termed as CD45+ CTCs) that resisted T cell attack. A higher percentage of CD45+ CTCs was found to be closely correlated with higher incidence of metastasis and worse prognosis in cancer patients. Moreover, CD45+ tumor cells orchestrated an immunosuppressive milieu and CD45+ CTCs exhibited remarkably stronger metastatic potential than CD45− CTCs in vivo. Mechanistically, CD45 expressing on tumor surfaces was shown to form intercellular CD45-CD45 homophilic interactions with CD45 on T cells, thereby preventing CD45 exclusion from TCR-pMHC synapse and leading to diminished TCR signaling transduction and suppressed immune response. Together, these results pointed to an underappreciated capability of EVs-derived CD45-dressed CTCs in immune evasion and metastasis, providing a rationale for targeting EVs-derived CD45 internalization by CTCs to prevent cancer metastasis.Keywords
This publication has 48 references indexed in Scilit:
- Circulating tumour cells: The Good, the Bad and the UglyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023
- Isolation of circulating tumor cellsiScience, 2022
- The bone microenvironment invigorates metastatic seeds for further disseminationCell, 2021
- Efficacy of Circulating Tumor Cell Count–Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast CancerJAMA Oncology, 2021
- Exosome-Mediated Metastasis: Communication from a DistanceDevelopmental Cell, 2019
- Exosomes in cancer development, metastasis, and immunityBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2019
- Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and MemoryCell, 2019
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- The Differential Regulation of Lck Kinase Phosphorylation Sites by CD45 Is Critical for T Cell Receptor Signaling ResponsesImmunity, 2007
- T Cell Receptor-Proximal Signals Are Sustained in Peripheral Microclusters and Terminated in the Central Supramolecular Activation ClusterImmunity, 2006